288
Views
60
CrossRef citations to date
0
Altmetric
Original Research

Impact of hypoglycemia on patients with type 2 diabetes mellitus and their quality of life, work productivity, and medication adherence

, , , &
Pages 683-692 | Published online: 08 May 2014

References

  • International Diabetes Foundation (IDF)Risk Factors for Diabetes2005 Available from: http://www.cvd.idf.org/Diabetes/Risk_Factors_for_Diabetes/index.htmlAccessed March 14, 2013
  • InzucchiSEBergenstalRMBuseJBManagement of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetes Care2012351364137922517736
  • RodbardHWJellingerPSDavidsonJAStatement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic controlEndocr Pract20091554055919858063
  • BarendseSSinghHFrierBMSpeightJThe impact of hypoglycaemia on quality of life and related patient-reported outcomes in type 2 diabetes: a narrative reviewDiabet Med20122929330221838763
  • BarnettAHCradockSFisherMHallGHughesEMiddletonAKey considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetesInt J Clin Pract2010641121112920236369
  • WeitzmanERKelemenSQuinnMEgglestonEMMandiKDParticipatory surveillance of hypoglycemia and harms in an online social networkJAMA Intern Med201317334535123400234
  • MoghissiEIsmail-BeigiFDevineRCHypoglycemia: minimizing its impact in type 2 diabetesEndocr Pract20131952653523425655
  • CryerPEThe barrier of hypoglycemia in diabetesDiabetes2008573169317619033403
  • AmielSADixonTMannRJamesonKHypoglycaemia in type 2 diabetesDiabet Med20082524525418215172
  • DiBonaventuraMDWagnerJSYuanYL’ItalienGLangleyPRay KimWHumanistic and economic impacts of hepatitis C infection in the United StatesJ Med Econ20101370971821091098
  • FinkelsteinEAAllaireBTDiBonaventuraMDBurgessSMDirect and indirect costs and potential cost savings of laparoscopic adjustable gastric banding among obese patients with diabetesJ Occup Environ Med2011531025102921866052
  • BolgeSCDoanJFKannanHBaranRWAssociation of insomnia with quality of life, work productivity, and activity impairmentQual Life Res20091841542219288223
  • Centers for Disease Control and PreventionNumber (in millions) of civilian, noninstitutionalized adults with diagnosed diabetes, United States, 1980–2011322013 Available from: http://www.cdc.gov/diabetes/statistics/prev/national/figadults.htmAccessed November 6, 2013
  • MonamiMLambertucciLLamannaCAre comorbidity indices useful in predicting all-cause mortality in type 2 diabetic patients? Comparison between Charlson index and disease countAging Clin Exp Res20071949249618172372
  • McEwenLNKarterAJWaitzfelderBEPredictors of mortality over 8 years in type 2 diabetic patients: Translating Research Into Action for Diabetes (TRIAD)Diabetes Care2012351301130922432119
  • MoriskyDEAngAKrousel-WoodMWardHJPredictive validity of a medication adherence measure in an outpatient settingJ Clin Hypertens (Greenwich)20081034835418453793
  • Al-QazazHKHassaliMAShafieAASulaimanSASundramSMoriskyDEThe eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian versionDiabetes Res Clin Pract20109021622120832888
  • KrapekKKingKWarrenSSMedication adherence and associated hemoglobin A1c in type 2 diabetesAnn Pharmacother2004381357136215238621
  • JamousRMSweilehWMAbu-TahaASSawalhaAFZyoudSHMoriskyDEAdherence and satisfaction with oral hypoglycemic medications: a pilot study in PalestineInt J Clin Pharm20113394294821918840
  • AikensJEPietteJDLongitudinal association between medication adherence and glycaemic control in type 2 diabetesDiabet Med20133033834423075262
  • WareJESnowKKKosinskiMGandekBSF-36® Health Survey Manual and Interpretation GuideBoston, MANew England Medical Center, The Health Institute1993
  • BestJDDruryPLDavisTMEGlycemic control over 5 years in 4,900 people with type 2 diabetesDiabetes Care2012351165117022432105
  • PollackMFPurayidathilFWBolgeSCWilliamsSAPatient-reported tolerability issues with oral antidiabetic agents: associations with adherence; treatment satisfaction and health-related quality of lifeDiabetes Res Clin Pract20108720421020036433
  • Alvarez GuisasolaFTofe PovedanoSKrishnarajahGLyuRMavrosPYinDHypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic control in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) StudyDiabetes Obes Metab200810Suppl 1253218435671
  • BronMMarynchenkoMYangHYuAPWuEQHypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugsPostgrad Med201212412413222314122
  • AscheCLeFleurJConnerCA review of diabetes treatment adherence and the association with clinical and economic outcomesClin Ther2011337410921397776
  • NohRMGravelingAJFrierBMMedically minimizing the impact of hypoglycaemia in type 2 diabetes: a reviewExpert Opin Pharmacother2011122161217521668402
  • ZoungasSPatelAChalmersJSevere hypoglycemia and risks of vascular events and deathN Engl J Med20103631410141820925543
  • BondsDEMillerMEBergenstalRMThe association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD studyBMJ2010340b490920061358